Prognostic impact of metformin in diabetic patients undergoing a percutaneous coronary intervention (PCI): protective effect is modified by procedural complexity
Abstract Background Metformin, a widely prescribed glucose-lowering agent, has demonstrated cardiovascular benefits in patients with diabetes who do not have established atherosclerotic cardiovascular disease. However, evidence regarding its role specifically in patients with diabetes undergoing per...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2026-02-01
|
| Seri Bilgileri: | Cardiovascular Diabetology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12933-026-03102-6 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|